Clinical Trials Browser

Withdrawn × Disease Progression × Thoracic × Clear all

NCT05116618 2022-09-21

Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged

Carcinoma, Non-Small-Cell Lung, Disease Progression

NCT02538432 2019-11-04

Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

Phase 2 Withdrawn

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Disease Progression

NCT01210131 2013-08-27

HX4 in SCLC

Phase NA Withdrawn

Disease Progression, Small Cell Lung Carcinoma